# A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

> **NCT06322641** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 300 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease (ASCVD)
- Chronic Kidney Disease (CKD)
- Systemic Inflammation

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT06322641
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-26
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-05-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06322641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06322641, "A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06322641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*